Cap displayed in your preferred currency (USD)
Industries & Sectors
| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| United States (Primary) | PRIMARYUSA | Univ | 6,179 | 73,614,390 | 0.06% | 0.72% | 2.20% | 5.77% | 17.01% | 13.02% |
| Healthcare | HEALTHCARE | Sector | 1,168 | 6,985,044 | 1.17% | 4.61% | 7.39% | 13.57% | 19.27% | 7.19% |
| Biopharmaceuticals | BIOPHARMA | SubSec | 600 | 3,574,436 | 1.42% | 6.50% | 10.81% | 20.53% | 30.54% | 19.30% |
| System-Specific Biopharmaceuticals | BIOPHARMASYS | Industry | 285 | 1,564,176 | 1.95% | 7.76% | 18.03% | 34.08% | 35.80% | 22.87% |
| Neurology Biopharmaceuticals | NEUROLOGY | SubInd | 94 | 115,327 | -0.10% | 3.18% | 7.04% | 17.73% | 25.71% | 0.88% |
Show Stocks
Sort: 1Mo %
| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| Praxis Precision Medicines, Inc. | PRAX:USAPRAX:USA | Stock | 1 | 3,886 | 0.03% | 11.52% | 249.60% | 290.00% | 393.58% | 116.44% |
| Edgewise Therapeutics, Inc. | EWTX:USAEWTX:USA | Stock | 1 | 2,239 | -1.44% | 21.88% | 44.01% | 49.61% | 46.51% | -40.08% |
| Harmony Biosciences Holdings, Inc. | HRMY:USAHRMY:USA | Stock | 1 | 1,932 | 1.70% | 6.99% | 24.96% | -9.03% | -2.02% | -6.60% |
| Dyne Therapeutics, Inc. | DYN:USADYN:USA | Stock | 1 | 2,654 | -5.39% | -10.96% | 20.45% | 50.32% | 58.52% | -33.84% |
| ACADIA Pharmaceuticals, Inc. | ACAD:USAACAD:USA | Stock | 1 | 4,081 | 1.73% | 8.06% | 18.52% | -4.74% | 37.10% | 32.07% |
| Denali Therapeutics, Inc. | DNLI:USADNLI:USA | Stock | 1 | 2,569 | -0.34% | 17.66% | 15.19% | 19.18% | 23.73% | -44.52% |
| Axsome Therapeutics, Inc. | AXSM:USAAXSM:USA | Stock | 1 | 7,086 | 0.90% | 3.81% | 14.04% | 28.97% | 31.37% | 54.83% |
| PTC Therapeutics, Inc. | PTCT:USAPTCT:USA | Stock | 1 | 5,991 | 1.53% | 4.43% | 13.41% | 53.52% | 65.42% | 67.04% |
| GH Research PLC | GHRS:USAGHRS:USA | Stock | 1 | 930 | 5.49% | 10.38% | 12.61% | 17.28% | 40.19% | 65.93% |
| Catalyst Pharmaceuticals, Inc. | CPRX:USACPRX:USA | Stock | 1 | 2,808 | -1.39% | 6.55% | 12.16% | 12.61% | -4.21% | -2.86% |
| Biogen, Inc. | BIIB:USABIIB:USA | Stock | 1 | 23,689 | 1.20% | 5.25% | 11.13% | 16.51% | 30.54% | -6.13% |
| Dianthus Therapeutics, Inc. | DNTH:USADNTH:USA | Stock | 1 | 1,659 | 7.26% | 14.79% | 8.93% | 86.69% | 106.51% | 39.53% |
| Prothena Corp. Plc | PRTA:USAPRTA:USA | Stock | 1 | 584 | 3.53% | 5.65% | 7.21% | 31.52% | 61.58% | -39.99% |
| Neurology Biopharmaceuticals | NEUROLOGY | SubInd | 94 | 115,327 | -0.10% | 3.18% | 7.04% | 17.73% | 25.71% | 0.88% |
| Neurocrine Biosciences, Inc. | NBIX:USANBIX:USA | Stock | 1 | 14,641 | -0.30% | -4.49% | 7.01% | 10.50% | 22.10% | 15.48% |
| S&P 500 | SPY:USASPY:USA | Benchmark | 14,204 | 97,233,754 | 0.06% | 0.86% | 3.19% | 6.50% | 16.40% | 15.52% |
| REGENXBIO, Inc. | RGNX:USARGNX:USA | Stock | 1 | 587 | 0.43% | -0.09% | 3.11% | 31.52% | 34.26% | 0.35% |
| Jazz Pharmaceuticals Plc | JAZZ:USAJAZZ:USA | Stock | 1 | 8,304 | -0.29% | -0.37% | 2.17% | 16.08% | 28.89% | 7.54% |
| Rapport Therapeutics, Inc. | RAPP:USARAPP:USA | Stock | 1 | 1,199 | -1.29% | -3.82% | 1.17% | 71.17% | 158.02% | -6.43% |
| Alkermes Plc | ALKS:USAALKS:USA | Stock | 1 | 5,185 | -7.11% | 1.08% | -1.68% | 8.11% | 0.62% | 4.42% |
| Xenon Pharmaceuticals, Inc. | XENE:USAXENE:USA | Stock | 1 | 3,060 | -0.60% | 2.64% | -2.19% | 3.79% | 34.19% | -9.96% |
| Scholar Rock Holding Corp. | SRRK:USASRRK:USA | Stock | 1 | 2,959 | 0.10% | 10.11% | -3.39% | -1.88% | -0.03% | 9.48% |
| Mind Medicine (MindMed), Inc. | MNMD:USAMNMD:USA | Stock | 1 | 932 | -2.72% | 5.29% | -3.80% | 26.33% | 85.34% | 35.34% |
| Supernus Pharmaceuticals, Inc. | SUPN:USASUPN:USA | Stock | 1 | 2,549 | -3.23% | -5.29% | -9.35% | 4.52% | 37.38% | 21.88% |
| Taysha Gene Therapies, Inc. | TSHA:USATSHA:USA | Stock | 1 | 1,194 | 1.87% | 8.19% | -15.42% | 48.30% | 70.31% | 167.48% |
| Sarepta Therapeutics, Inc. | SRPT:USASRPT:USA | Stock | 1 | 1,886 | 0.11% | -3.59% | -16.01% | -17.47% | -48.97% | -84.73% |
| Anavex Life Sciences Corp. | AVXL:USAAVXL:USA | Stock | 1 | 589 | 0.73% | -5.61% | -21.55% | -30.62% | -17.56% | -24.59% |
| Atai Beckley NV | ATAI:USAATAI:USA | Stock | 1 | 919 | -2.26% | -3.35% | -27.83% | 11.60% | 165.64% | 174.05% |
| Stoke Therapeutics, Inc. | STOK:USASTOK:USA | Stock | 1 | 1,385 | 0.08% | 10.12% | -28.08% | 38.00% | 160.96% | 81.97% |
| Biohaven Ltd. | BHVN:USABHVN:USA | Stock | 1 | 841 | -6.69% | -4.68% | -52.28% | -49.40% | -49.75% | -84.84% |
| MapLight Therapeutics, Inc. | MPLT:USAMPLT:USA | Stock | 1 | 599 | -4.05% | -9.62% | N/A | N/A | N/A | N/A |
* Colors indicate performance relative to the benchmark.